What is the current stock price of E-Qure Corp. (EQUR)?

As of the latest market data, E-Qure Corp. (EQUR) is trading at $0.00. The stock has seen a loss of -99.50% today.

Does E-Qure Corp. (EQUR) pay a dividend?

Based on current data, E-Qure Corp. does not have a confirmed active dividend policy.

What is the market cap of E-Qure Corp.?

The current market capitalization of E-Qure Corp. (EQUR) is approximately unavailable.

EQUR

E-Qure Corp.·Healthcare

0.00

99.499%(−0.04)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.05

EQUR NEWS

defenseworld.net

Mar 26

Head-To-Head Review: Waters (NYSE:WAT) and ADB International Group (OTCMKTS:EQUR)

ADB International Group (OTCMKTS:EQUR - Get Free Report) and Waters (NYSE: WAT - Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Valuation and Earnings This table compares ADB International

defenseworld.net

Mar 23

Contrasting Delcath Systems (NASDAQ:DCTH) & ADB International Group (OTCMKTS:EQUR)

Delcath Systems (NASDAQ: DCTH - Get Free Report) and ADB International Group (OTCMKTS:EQUR - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Profitability This table compares Delcath Systems and

defenseworld.net

Mar 2

Analyzing ADB International Group (OTCMKTS:EQUR) & Neuronetics (NASDAQ:STIM)

Neuronetics (NASDAQ: STIM - Get Free Report) and ADB International Group (OTCMKTS:EQUR - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings. Valuation and Earnings This table compares Neuronetics and

Company Profile

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

1994-10-31

Beta

1.15

Websitewww.e-qure.com↗